Search

Search Constraints

You searched for: Author/Creator Salas, S.

Search Results

1. A phase I dose expansion study of NBTXR3, radiation enhancing hafnium oxide nanoparticles, for the treatment of cisplatin-ineligible locally advanced HNSCC patients. (December 2021)

2. Bleeding risk of terminally ill patients hospitalized in palliative care units: the RHESO study. (17th February 2017)

3. Efficacy of a global supportive skin care programme with hydrotherapy after non‐metastatic breast cancer treatment: A randomised, controlled study. (22nd August 2017)

5. Meta‐analysis of the influence of surgical margin and adjuvant radiotherapy on local recurrence after resection of sporadic desmoid‐type fibromatosis. Issue 4 (15th February 2017)

6. Meta‐analysis of the influence of surgical margin and adjuvant radiotherapy on local recurrence after resection of sporadic desmoid‐type fibromatosis. Issue 4 (March 2017)

7. OC-043 HNSCC in elderly frail patients treated by hafnium oxide nanoparticles activated by IMRT. (March 2019)

8. OC-0515 NBTXR3 activated by radiotherapy in cisplatin-ineligible locally advanced HNSCC patients. (August 2021)

9. OC-0560: RT-activated hafnium oxide nanoparticles in cisplatin-ineligible locally advanced HNSCC patients. (November 2020)